Аннотация
Physiologically, pregnancy induces a state of progressive insulin resistance to ensure adequate glucose supply for the growing fetus. While this adaptation is beneficial in normal pregnancies, in predisposed women it leads to hyperglycemia, β-cell dysfunction, and the clinical manifestation of GDM. Elevated levels of placental hormones — including human placental lactogen (hPL), cortisol, estrogen, progesterone, and placental growth hormone — antagonize insulin action, decrease maternal insulin sensitivity, and alter lipid and carbohydrate metabolism.
Библиографические ссылки
American Diabetes Association. (2023). Classification and diagnosis of diabetes: Standards of medical care in diabetes—2023. Diabetes Care, 46(Suppl. 1), S19–S40. https://doi.org/10.2337/dc23-S002
Buchanan, T. A., & Xiang, A. H. (2005). Gestational diabetes mellitus. The Journal of Clinical Investigation, 115(3), 485–491. https://doi.org/10.1172/JCI24102
Catalano, P. M., & Shankar, K. (2017). Obesity and pregnancy: Mechanisms of short term and long term adverse consequences for mother and child. BMJ, 356, j1. https://doi.org/10.1136/bmj.j1
Hadden, D. R. (2018). Gestational diabetes: The new epidemic. Clinical Medicine, 18(2), 123–126. https://doi.org/10.7861/clinmedicine.18-2-123